EE200300138A - Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid - Google Patents

Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid

Info

Publication number: EE200300138A
Authority: EE; Estonia
Prior art keywords: pseudoephedrine; pharmaceutical compositions; compositions containing; containing epinastine; epinastine
Prior art date: 2000-10-06

Application number

EEP200300138A

Other languages

English (en)

Estonian (et)

Inventor

Abelaira Sara

Bianchi Daniel

Gel Francisco

Denker Victor

Fernandez Mabel

Cicconi De Vidal Marta

Original Assignee

Boehringer Ingelheim International Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-06

Filing date

2001-09-28

Publication date

2003-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300138(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-28 Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh

2003-08-15 Publication of EE200300138A publication Critical patent/EE200300138A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EEP200300138A 2000-10-06 2001-09-28 Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid EE200300138A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00121828		2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en)	2000-10-06	2001-09-28	New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (1)

Publication Number	Publication Date
EE200300138A true EE200300138A (et)	2003-08-15

Family

ID=8170029

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300138A EE200300138A (et)	2000-10-06	2001-09-28	Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid

Country Status (31)

Country	Link
EP (1)	EP1326586B1 (zh)
JP (1)	JP2004521864A (zh)
KR (1)	KR20030036894A (zh)
CN (1)	CN1291715C (zh)
AR (2)	AR032479A1 (zh)
AT (1)	ATE424813T1 (zh)
AU (2)	AU1229002A (zh)
BG (1)	BG107686A (zh)
BR (1)	BR0114339A (zh)
CA (1)	CA2423288C (zh)
CZ (1)	CZ2003945A3 (zh)
DE (1)	DE60137952D1 (zh)
EA (1)	EA007288B1 (zh)
EC (1)	ECSP034513A (zh)
EE (1)	EE200300138A (zh)
ES (1)	ES2323570T3 (zh)
HR (1)	HRP20030259A2 (zh)
HU (1)	HUP0300970A3 (zh)
IL (1)	IL154884A0 (zh)
ME (1)	MEP39708A (zh)
MX (1)	MXPA03002900A (zh)
MY (1)	MY131159A (zh)
NO (1)	NO20031537L (zh)
NZ (1)	NZ525653A (zh)
PE (1)	PE20020324A1 (zh)
PL (1)	PL366123A1 (zh)
SK (1)	SK4052003A3 (zh)
UA (1)	UA75896C2 (zh)
WO (1)	WO2002028373A1 (zh)
YU (1)	YU24603A (zh)
ZA (1)	ZA200302079B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0401630A2 (hu) *	2001-06-20	2004-12-28	Schering Corp.	Antihisztaminok alkalmazása nazális vérbőség és orrdugulás kezelésére szolgáló gyógyszerkészítmény előállítására
JP4549618B2 (ja) *	2001-11-22	2010-09-22	第一三共ヘルスケア株式会社	鼻炎用組成物
CA2494065A1 (en) *	2002-08-02	2004-02-19	Boehringer Ingelheim International Gmbh	Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5021155B2 (ja) *	2003-08-01	2012-09-05	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
US20070196396A1 (en) *	2004-02-11	2007-08-23	Rubicon Research Private Limited	Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0903151A1 (en) *	1997-09-22	1999-03-24	ASTA Medica Aktiengesellschaft	Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
WO1999032125A1 (en) *	1997-12-23	1999-07-01	Schering Corporation	Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
WO2000021512A2 (en) *	1998-10-09	2000-04-20	Schering Corporation	Composition and method for treating allergic diseases
US6613357B2 (en) *	2000-01-13	2003-09-02	Osmotica Corp.	Osmotic device containing pseudoephedrine and an H1 antagonist

2001
- 2001-09-04 PE PE2001000883A patent/PE20020324A1/es not_active Application Discontinuation
- 2001-09-28 CZ CZ2003945A patent/CZ2003945A3/cs unknown
- 2001-09-28 BR BR0114339-5A patent/BR0114339A/pt not_active Application Discontinuation
- 2001-09-28 KR KR10-2003-7004846A patent/KR20030036894A/ko not_active Ceased
- 2001-09-28 YU YU24603A patent/YU24603A/sh unknown
- 2001-09-28 SK SK405-2003A patent/SK4052003A3/sk unknown
- 2001-09-28 IL IL15488401A patent/IL154884A0/xx unknown
- 2001-09-28 JP JP2002531999A patent/JP2004521864A/ja active Pending
- 2001-09-28 ME MEP-397/08A patent/MEP39708A/xx unknown
- 2001-09-28 AU AU1229002A patent/AU1229002A/xx active Pending
- 2001-09-28 NZ NZ525653A patent/NZ525653A/en unknown
- 2001-09-28 CA CA002423288A patent/CA2423288C/en not_active Expired - Lifetime
- 2001-09-28 UA UA2003054060A patent/UA75896C2/uk unknown
- 2001-09-28 EP EP01980449A patent/EP1326586B1/en not_active Expired - Lifetime
- 2001-09-28 AU AU2002212290A patent/AU2002212290B2/en not_active Ceased
- 2001-09-28 AT AT01980449T patent/ATE424813T1/de active
- 2001-09-28 WO PCT/EP2001/011229 patent/WO2002028373A1/en not_active Ceased
- 2001-09-28 EA EA200300430A patent/EA007288B1/ru not_active IP Right Cessation
- 2001-09-28 ES ES01980449T patent/ES2323570T3/es not_active Expired - Lifetime
- 2001-09-28 EE EEP200300138A patent/EE200300138A/xx unknown
- 2001-09-28 HR HR20030259A patent/HRP20030259A2/hr not_active Application Discontinuation
- 2001-09-28 DE DE60137952T patent/DE60137952D1/de not_active Expired - Lifetime
- 2001-09-28 PL PL01366123A patent/PL366123A1/xx unknown
- 2001-09-28 CN CNB018169376A patent/CN1291715C/zh not_active Expired - Lifetime
- 2001-09-28 MX MXPA03002900A patent/MXPA03002900A/es active IP Right Grant
- 2001-09-28 HU HU0300970A patent/HUP0300970A3/hu unknown
- 2001-10-04 MY MYPI20014635A patent/MY131159A/en unknown
- 2001-10-05 AR ARP010104692A patent/AR032479A1/es not_active Application Discontinuation
2003
- 2003-03-13 EC EC2003004513A patent/ECSP034513A/es unknown
- 2003-03-14 ZA ZA200302079A patent/ZA200302079B/en unknown
- 2003-03-28 BG BG107686A patent/BG107686A/bg unknown
- 2003-04-04 NO NO20031537A patent/NO20031537L/no not_active Application Discontinuation
2012
- 2012-07-19 AR ARP120102612A patent/AR087240A2/es unknown

Also Published As

Publication number	Publication date
ZA200302079B (en)	2004-05-05
UA75896C2 (en)	2006-06-15
NO20031537L (no)	2003-06-04
AR087240A2 (es)	2014-03-12
DE60137952D1 (de)	2009-04-23
MEP39708A (en)	2011-02-10
CA2423288C (en)	2007-11-13
EA200300430A1 (ru)	2003-10-30
ES2323570T3 (es)	2009-07-21
JP2004521864A (ja)	2004-07-22
HRP20030259A2 (en)	2005-02-28
HUP0300970A2 (hu)	2003-11-28
EA007288B1 (ru)	2006-08-25
ECSP034513A (es)	2003-04-25
AR032479A1 (es)	2003-11-12
CA2423288A1 (en)	2002-04-11
WO2002028373A1 (en)	2002-04-11
BG107686A (bg)	2003-11-28
AU2002212290B2 (en)	2006-08-03
MXPA03002900A (es)	2003-09-10
CN1468094A (zh)	2004-01-14
BR0114339A (pt)	2003-12-09
CN1291715C (zh)	2006-12-27
PE20020324A1 (es)	2002-06-18
ATE424813T1 (de)	2009-03-15
EP1326586B1 (en)	2009-03-11
NO20031537D0 (no)	2003-04-04
AU1229002A (en)	2002-04-15
SK4052003A3 (en)	2003-09-11
YU24603A (sh)	2006-05-25
KR20030036894A (ko)	2003-05-09
PL366123A1 (en)	2005-01-24
HUP0300970A3 (en)	2005-03-29
HK1062196A1 (zh)	2004-10-21
IL154884A0 (en)	2003-10-31
MY131159A (en)	2007-07-31
NZ525653A (en)	2006-07-28
CZ2003945A3 (cs)	2003-08-13
EP1326586A1 (en)	2003-07-16

Publication	Publication Date	Title
NO20025450L (no)	2002-11-14	Ny farmasöytisk sammensetning
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
DE69924999D1 (de)	2005-06-02	Lipasehemmer enthaltende pharmazeutische zusammensetzungen
EE200300145A (et)	2003-06-16	Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
EP1298180A4 (en)	2005-03-09	HYDROPHOBIC AND LIPOPHOBE COMPOSITION
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
DE60127002D1 (de)	2007-04-12	Pharmazeutische zusammensetzung
NO20005913D0 (no)	2000-11-22	Legemiddelsammensetning
ID27415A (id)	2001-04-05	Komposisi farmaseutik
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EA199900373A3 (ru)	2000-08-28	Фармацевтические композиции
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
ID29262A (id)	2001-08-16	Komposisi farmasi
ID27201A (id)	2001-03-08	Komposisi farmasi
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
NO20031095D0 (no)	2003-03-10	Farmasöytiske sammensetninger
ITMI20011637A0 (it)	2001-07-27	Composizione farmaceutica contenente citalopram
NO20030156L (no)	2003-03-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
EE200300138A (et)	2003-08-15	Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid
ID26215A (id)	2000-12-07	Komposisi farmasi
EE200200689A (et)	2004-06-15	Ravimkoostised
SE9803771D0 (sv)	1998-11-05	Pharmaceutical composition and use
SE9904414D0 (sv)	1999-12-03	Pharmaceutical composition and use